honokiol has been researched along with Angiogenesis, Pathologic in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (35.29) | 29.6817 |
| 2010's | 9 (52.94) | 24.3611 |
| 2020's | 2 (11.76) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Chen, L; Jie, S; Li, S; Liang, X; Luo, Y; Ma, L; Peng, A; Peng, M; Wang, T; Wang, X; Wei, Y; Zhu, W | 1 |
| Chen, T; Cheng, X; Fan, L; Huang, Y; Qiao, Y; Shen, X; Wang, F; Wei, M; Yu, D | 1 |
| Aghi, MK; Chandra, A; Chen, W; Diaz, AA; Garcia, JH; Gilbert, LA; Jahangiri, A; Jain, S; Joshi, RS; Kumar, S; Lin, JG; Müller, S; Nguyen, AT; Pereira, MP; Rick, JW; Shah, SS; Wadhwa, H; Weiss, J; Wolf, KJ; Yagnik, G | 1 |
| Balan, M; Chakraborty, S; Flynn, E; Pal, S; Zurakowski, D | 1 |
| Cheng, L; Ju, RJ; Li, CQ; Li, XT; Liu, S; Peng, XM; Qiu, X; Song, XL; Wang, T | 1 |
| Bai, P; Bian, Y; Cheng, Z; Liang, L; Wan, J; Wang, F; Wang, S; Xue, F | 1 |
| Kanjilal, D; Mukherji, M; Ponnaluri, VK; Vavilala, DT | 1 |
| Mukherji, M; Subhani, S; Vavilala, DT | 1 |
| Gao, X; Guo, G; Hu, X; Liu, X; Liu, Y; Mao, Q; Wang, X; Xu, G; You, C; Yu, T; Zhou, L | 1 |
| Chen, L; Chen, X; Hou, W; Hu, J; Jiang, Q; Tang, M; Wang, X; Wei, Y; Wen, J; Yang, G; Yuan, Y; Zhong, Z; Zhou, H | 1 |
| Chen, LJ; Fan, LY; Guo, WH; Hou, WL; Jiang, QQ; Wei, YQ; Yang, GL | 1 |
| Chen, LJ; Chen, PL; Chen, X; Hou, WL; Hu, J; Liu, L; Tang, MH; Wang, XH; Wei, YQ; Yang, G; Zhang, F; Zhao, X | 1 |
| Mitra, AK; Mukherji, M; Pal, D; Ponnaluri, VK; Vadlapatla, RK; Vavilala, DT | 1 |
| Chen, YC; Cheng, HC; Lan, KH; Lee, WJ; Liao, KK; Liu, SH; Pan, HC; Peng, YC; Shen, CC; Sheu, ML; Wang, KB; Wu, SM | 1 |
| Anderson, KC; Arbiser, J; Chauhan, D; Hamasaki, M; Hideshima, H; Hideshima, T; Ishitsuka, K; Kumar, S; Le Gouill, S; Podar, K; Raje, N; Richardson, P; Roccaro, AM; Shiraishi, N; Tamura, K; Yasui, H | 1 |
| Arbiser, JL; Bhandarkar, S; Cance, WG; Funa, NS; Kurenova, EV; Reddy, K; Welsh, M; Yang, L | 1 |
| Chen, L; Huang, C; Li, Z; Liu, Y; Pan, X; Wei, Y; Yin, R; Zhao, X | 1 |
1 review(s) available for honokiol and Angiogenesis, Pathologic
| Article | Year |
|---|---|
HIF inhibitors for ischemic retinopathies and cancers: options beyond anti-VEGF therapies.
Topics: Angiogenesis Inducing Agents; Angiogenesis Inhibitors; Animals; Anthracyclines; Biphenyl Compounds; Cardiac Glycosides; Humans; Hypoxia-Inducible Factor 1; Indazoles; Lignans; Models, Biological; Neoplasms; Neovascularization, Pathologic; Retinal Neovascularization; Vascular Endothelial Growth Factors | 2016 |
16 other study(ies) available for honokiol and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Structural modification of honokiol, a biphenyl occurring in Magnolia officinalis: the evaluation of honokiol analogues as inhibitors of angiogenesis and for their cytotoxicity and structure-activity relationship.
Topics: Allyl Compounds; Angiogenesis Inhibitors; Animals; Animals, Genetically Modified; Benzaldehydes; Biphenyl Compounds; Cell Line; Cell Line, Tumor; Cell Movement; Cell Proliferation; Drug Screening Assays, Antitumor; Embryo, Nonmammalian; Endothelial Cells; Endothelium, Vascular; Humans; In Vitro Techniques; Lignans; Magnolia; Neovascularization, Pathologic; Neovascularization, Physiologic; Structure-Activity Relationship; Zebrafish | 2011 |
Honokiol inhibits interleukin-induced angiogenesis in the NSCLC microenvironment through the NF-κB signaling pathway.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Human Umbilical Vein Endothelial Cells; Humans; Interleukins; Lung Neoplasms; Neovascularization, Pathologic; NF-kappa B; Signal Transduction; Tumor Microenvironment; Vascular Endothelial Growth Factor A | 2023 |
Clonal ZEB1-Driven Mesenchymal Transition Promotes Targetable Oncologic Antiangiogenic Therapy Resistance.
Topics: Adult; Aged; Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Biphenyl Compounds; Brain; Brain Neoplasms; Cell Hypoxia; Cell Line, Tumor; Chitinase-3-Like Protein 1; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Glioblastoma; Human Umbilical Vein Endothelial Cells; Humans; Lignans; Male; Middle Aged; Neoplasm Invasiveness; Neoplastic Stem Cells; Neovascularization, Pathologic; Tumor Microenvironment; Up-Regulation; Xenograft Model Antitumor Assays; Young Adult; Zinc Finger E-box-Binding Homeobox 1 | 2020 |
Honokiol inhibits c-Met-HO-1 tumor-promoting pathway and its cross-talk with calcineurin inhibitor-mediated renal cancer growth.
Topics: Animals; Apoptosis; Biphenyl Compounds; Calcineurin Inhibitors; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Down-Regulation; Heme Oxygenase-1; Hepatocyte Growth Factor; Human Umbilical Vein Endothelial Cells; Humans; Kidney Neoplasms; Lignans; Mice, Nude; Neovascularization, Pathologic; Neovascularization, Physiologic; Phosphorylation; Proto-Oncogene Proteins c-met; ras Proteins | 2017 |
Hyaluronic acid modified daunorubicin plus honokiol cationic liposomes for the treatment of breast cancer along with the elimination vasculogenic mimicry channels.
Topics: Animals; Biphenyl Compounds; Breast Neoplasms; Cations; Daunorubicin; Female; Humans; Hyaluronic Acid; Lignans; Liposomes; MCF-7 Cells; Mice; Neovascularization, Pathologic | 2018 |
[Honokiol inhibits the invasion and angiogenesis of U937 leukemia cells].
Topics: Antineoplastic Agents; Biphenyl Compounds; Cell Adhesion; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Leukemia; Lignans; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Neovascularization, Pathologic; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1 | 2014 |
Evaluation of anti-HIF and anti-angiogenic properties of honokiol for the treatment of ocular neovascular diseases.
Topics: Angiogenesis Inhibitors; Biphenyl Compounds; Cell Line; Cell Movement; Cell Proliferation; Endothelium, Vascular; Eye Diseases; HeLa Cells; Humans; Hypoxia-Inducible Factor 1; Lignans; Luciferases; Neovascularization, Pathologic; Retinal Pigment Epithelium | 2014 |
Enhancing the anti-glioma therapy of doxorubicin by honokiol with biodegradable self-assembling micelles through multiple evaluations.
Topics: Animals; Antineoplastic Agents; Apoptosis; Biphenyl Compounds; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Doxorubicin; Drug Carriers; Drug Liberation; Drug Synergism; Humans; Lignans; Micelles; Nanoparticles; Neovascularization, Pathologic; Polyesters; Polyethylene Glycols; X-Ray Diffraction; Xenograft Model Antitumor Assays; Zebrafish | 2017 |
Synergistic antitumor effects of liposomal honokiol combined with adriamycin in breast cancer models.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Biphenyl Compounds; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Combinations; Drug Screening Assays, Antitumor; Drug Synergism; Drugs, Chinese Herbal; Female; Lignans; Liposomes; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Xenograft Model Antitumor Assays | 2008 |
Improved therapeutic effectiveness by combining liposomal honokiol with cisplatin in lung cancer model.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biphenyl Compounds; Cell Line, Tumor; Cisplatin; Humans; In Situ Nick-End Labeling; Lignans; Liposomes; Lung Neoplasms; Mice; Neoplasm Transplantation; Neovascularization, Pathologic; Plant Extracts; Platelet Endothelial Cell Adhesion Molecule-1 | 2008 |
Liposomal honokiol, a potent anti-angiogenesis agent, in combination with radiotherapy produces a synergistic antitumor efficacy without increasing toxicity.
Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Biphenyl Compounds; Carcinoma, Lewis Lung; Cell Cycle; Cell Line, Tumor; Combined Modality Therapy; Humans; Lignans; Liposomes; Lung Neoplasms; Magnolia; Mice; Neoplasm Transplantation; Neovascularization, Pathologic; Radiation Tolerance; Transplantation, Heterologous | 2008 |
Honokiol inhibits HIF pathway and hypoxia-induced expression of histone lysine demethylases.
Topics: Angiogenesis Inhibitors; Biphenyl Compounds; Cell Hypoxia; Cell Line; Cell Line, Tumor; Gene Expression; Histone Demethylases; Humans; Hypoxia; Hypoxia-Inducible Factor 1; Lignans; Neovascularization, Pathologic; Oxygen | 2012 |
Calpain/SHP-1 interaction by honokiol dampening peritoneal dissemination of gastric cancer in nu/nu mice.
Topics: Animals; Apoptosis; Biphenyl Compounds; Calpain; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Human Umbilical Vein Endothelial Cells; Humans; Lignans; Mice; Neovascularization, Pathologic; Phosphorylation; Protein Tyrosine Phosphatase, Non-Receptor Type 6; RNA, Small Interfering; Signal Transduction; STAT3 Transcription Factor; Stomach Neoplasms; Up-Regulation; Xenograft Model Antitumor Assays | 2012 |
Honokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspase-dependent and -independent apoptosis.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Biphenyl Compounds; Bone Marrow Cells; Caspases; Cell Cycle; Cell Line, Tumor; Cell Proliferation; DNA; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Endothelial Cells; Humans; Insulin-Like Growth Factor I; Interleukin-6; Lignans; Multiple Myeloma; Neovascularization, Pathologic; Stromal Cells; Structure-Activity Relationship | 2005 |
Shb gene knockdown increases the susceptibility of SVR endothelial tumor cells to apoptotic stimuli in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Biphenyl Compounds; Cell Line, Tumor; Cisplatin; Endothelial Cells; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Focal Adhesion Protein-Tyrosine Kinases; Hemangiosarcoma; In Vitro Techniques; Lignans; Mice; Mice, Nude; Mutagenesis; Neoplasm Transplantation; Neovascularization, Pathologic; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Staurosporine | 2008 |
Honokiol, a natural therapeutic candidate, induces apoptosis and inhibits angiogenesis of ovarian tumor cells.
Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Biphenyl Compounds; Cell Line, Tumor; Disease Models, Animal; Female; Humans; Lignans; Mice; Mice, Nude; Neovascularization, Pathologic; Ovarian Neoplasms | 2008 |